170 related articles for article (PubMed ID: 11196463)
1. p53 and Ki67 in adrenocortical tumors.
Arola J; Salmenkivi K; Liu J; Kahri AI; Heikkilä P
Endocr Res; 2000 Nov; 26(4):861-5. PubMed ID: 11196463
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Banerjee M
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
[TBL] [Abstract][Full Text] [Related]
5. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.
Bernini GP; Moretti A; Viacava P; Bonadio AG; Iacconi P; Miccoli P; Salvetti A
Br J Cancer; 2002 May; 86(10):1561-5. PubMed ID: 12085205
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
Takehara K; Sakai H; Shono T; Irie J; Kanetake H
Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
[TBL] [Abstract][Full Text] [Related]
8. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas.
Ilvesmäki V; Kahri AI; Miettinen PJ; Voutilainen R
J Clin Endocrinol Metab; 1993 Sep; 77(3):852-8. PubMed ID: 8370710
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
[TBL] [Abstract][Full Text] [Related]
12. Chromatin texture analysis of cortical adrenal gland adenomas, including incidentalomas, and adjacent normal-appearing cortical tissue.
Scarpelli M; Baccarini MG; Colanzi P; Arnaldi G; Montironi R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 2000 Jun; 22(3):235-43. PubMed ID: 10872041
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Mannelli M; Gelmini S; Arnaldi G; Becherini L; Bemporad D; Crescioli C; Pazzagli M; Mantero F; Serio M; Orlando C
J Clin Endocrinol Metab; 2000 Jan; 85(1):468-70. PubMed ID: 10634426
[TBL] [Abstract][Full Text] [Related]
17. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
18. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma.
Hao X; Du M; Bishop AE; Talbot IC
Virchows Arch; 1998 Dec; 433(6):523-7. PubMed ID: 9870685
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas.
Ilvesmäki V; Liu J; Heikkilä P; Kahri AI; Voutilainen R
Horm Metab Res; 1998 Oct; 30(10):619-23. PubMed ID: 9851669
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
